Pacific Biosciences of California (PACB) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • Wednesday
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio SequencingGlobeNewsWire • Tuesday
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 06/28/24
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant DatabasePRNewsWire • 06/10/24
Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 05/23/24
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare DiseasesPRNewsWire • 05/15/24
Pacific Biosciences of California, Inc. (PACB) Q1 2024 Earnings Call TranscriptSeeking Alpha • 05/10/24
Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 05/09/24
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/24
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 EarningsZacks Investment Research • 05/07/24
Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to KnowZacks Investment Research • 05/02/24
Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 WeeksZacks Investment Research • 04/25/24
Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 04/23/24
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase DelaysZacks Investment Research • 04/17/24
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidancePRNewsWire • 04/16/24